5paisa Capital is a digital discount broker whose economics depend on three linked engines: broking revenue from cash and derivatives, interest from the client funding book, and distribution and cross-sell. Broking is volume-linked and competitive; the funding book is balance-sheet-linked; cross-sell is smaller but can deepen the customer relationship. In FY26 the company reported revenue of ₹320 crore and PAT of ₹44 crore. Q1 FY27 revenue was ₹88.4 crore with PAT of ₹11.6 crore. Q2 FY27 revenue was ₹86.5 crore with PAT of ₹7.1 crore, and H1 revenue was about ₹175 crore, up 13% YoY. Management said Q2 profit was lower QoQ because it chose to keep investing in technology, product and brand while trading activity was slower across the market. That is the central tension in the thesis: the company has a larger product and capital base, but the reported earnings line has not yet shown operating leverage.
The capital position changed materially with the ₹468 crore rights issue completed in April 2026. Net worth was ₹1,136 crore at Q2 FY27 versus ₹650 crore at March 2026. The deployment was specific: ₹227 crore to exchange margin after RBI barred banks from giving brokers intraday facilities from 1 July 2026, ₹150 crore to repay bank and commercial-paper loans, and ₹88 crore to general corporate purpose. This is not a revenue line by itself. Exchange margin preserves the ability to carry client trading flow; loan repayment lowers finance cost; the general corporate purpose funds product, technology and marketing. The test is whether those uses produce a return above the cost of the capital, and management has not disclosed a return target or a time-bound revenue bridge.
The client funding book is the clearest controllable asset. The average book, covering MTF and T+5, rose from ₹422 crore in Q1 FY27 to about ₹480 crore in Q2 FY27, and management says it is spread across a large number of clients rather than concentrated in a few. Mutual fund AUM was ₹2,095 crore, up from ₹2,073 crore in Q1. These are useful signs of wallet deepening, but the Q2 mutual fund increase was small after 18% QoQ growth in Q1. No yield, credit-cost or NPA data was disclosed for the funding book, so the spread economics remain unproven.
The product rebuild is the operating-leverage lever. The new 5paisa trading and investing app has been rebuilt with new back-end APIs, a new OMS and RMS, and the Ask 5paisa AI assistant. Management capitalised about 62 million of build costs in Q2 FY27 and expects to pay it off over several years. It also plans an IPO-related product in the near future. The positive evidence is that 95% of customers who joined in Q2 opened accounts themselves and app users exceed 24 million. The missing evidence is revenue per customer, retention, or a production date for the rebuilt stack. My inference is that the product rebuild is necessary but not sufficient: for operating leverage to appear, revenue per customer must rise faster than tech, product and brand spend. The Q2 report does not yet show that.
Management delivery is mixed. The rights issue and its deployment were delivered with specificity. AlgoSpace was launched, but roughly a year after the “next couple of months” language. IntraEdge was promised for early Q2 FY26 and has not been evidenced since. The core re-platforming was promised for the quarter after October 2025 and was still being rebuilt in Q2 FY27. The Q1 FY27 call said growth should accelerate from those quarters and that management was targeting operating leverage within 12 months. Q2 revenue was lower QoQ and PAT fell to ₹7.1 crore. That does not prove the Q1 statement was wrong; it does mean the claim remains open.
The Trendline acquisition adds another option. The board approved it at the end of July 2026, but the formal acquisition still needed to close by the Q2 FY27 call. Management plans to bring Trendline's research-themed baskets, screeners and AI stack into 5paisa and will decide after closing whether to merge it legally. No consideration or completion date was disclosed. Until terms are known, this is a product-depth option rather than a measurable earnings contributor.
The earnings path over the next 2-3 years therefore depends on three observable milestones. First, Q3 FY27 revenue and PAT must recover from the Q2 decline; otherwise the operating-leverage thesis is deferred again. Second, the funding book must keep growing without a disclosed deterioration in spread or credit cost. Third, the rebuilt app and Trendline features must show up in revenue per customer or retention, not only in app-user counts. Management gave no quantitative revenue, margin or capex guidance in the Q2 FY27 call, so these are analyst tests, not company targets.
The falsifiers are concrete. If H2 FY27 revenue does not recover and PAT stays below the Q1 FY27 level while product and brand spend continues, operating leverage is not appearing. If the funding book stops growing or requires more capital without a disclosed spread, the balance-sheet engine is weaker than the bull case assumes. If Trendline closing slips or terms are dilutive, the acquisition adds uncertainty rather than product depth. If derivatives volumes stay soft and active NSE clients remain around 46 million, the F&O-heavy revenue base will keep limiting the upside. The thesis remains operating-leverage, but the evidence at Q2 FY27 is a company investing ahead of a recovery, not one that has already demonstrated it.
companyname: 5paisa Capital Limited ticker: 5PAISA sector: Discount Stock Broking / Fintech / Capital Markets 5paisa Capital Limited is a SEBI-registered stockbroker, depository participant, research analyst and AMFI-recognised mutual fund distributor. It was incorporated in 2007 as India Infoline Finance Holdings Limited, launched its discount broking business in 2016, and is part of the IIFL group. The company is listed on NSE (5PAISA) and BSE (540776) and headquartered in Thane, Maharashtra....
Read the full report →none
No quantitative revenue, margin or capex guidance was given in the Q2 FY27 call. Management said it will keep investing in technology, product and brand, capitalised about 62 million of platform-build costs with an expectation to pay it off over several years, and plans an IPO-related product in the near future.
Guidance upgradedmixed
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for 5paisa Capital Limited and 4,900+ companies.
5-day free pass. No card required.